Innovative Therapeutics Image Asier Unciti-Broceta - Personal Chair of Medicinal Chemistry Research in a Nutshell The Innovative Therapeutics Lab is led by Professor Asier Unciti-Broceta and based at Edinburgh Cancer Research, part of the Institute of Genetics and Cancer at the University of Edinburgh, where Asier established the first chemistry lab of the Institute in 2010. The lab explores novel chemical strategies to improve the efficacy and safety of cancer treatments. This includes development of highly-selective inhibitors of kinases involved in cancer and novel prodrug strategies aimed at improving the clinical use of well-established chemotherapy drugs.Research Programme People Asier Unciti-BrocetaProfessor of Medicinal Chemistry and Head of the Innovative Therapeutics LabCatherine AdamChemistry Lab ManagerAlvaro Lorente-MacíasLead Synthetic ChemistYang GeEPSRC Postdoctoral FellowAthina PolykandritouMRC Postdoctoral FellowDavir GonzálezEPSRC Postdoctoral FellowBobby KaghazchiNuvectis Postdoctoral FellowBen KingPhD studentIñigo Lanzagorta CalvilloPhD studentJonathon MockPhD studentRoss MilnesPhD studentAdam SmithPhD studentBen JonesVisiting PhD studentJohn Hajek5th year MChem studentContactasier.ub@ed.ac.uk Asier Unciti-Broceta - Research Information CollaborationsProfessor Neil Carragher (ECRC)Dr Liz Patton (ECRC)Professor Val Brunton (ECRC)Professor Margaret Frame (ECRC)Professor H. Leung (Beatson Institute / University of Glasgow)Dr P. Brennan (Centre for Clinical Brain Sciences / University of Edinburgh)Dr D. Sieger (Centre for Neuroregeneration / University of Edinburgh)Dr C. Torres-Sánchez (Loughborough University)Dr R. Sanchez-Martín and Dr J. J. Díaz-Mochón (GENyO / Spain)Professor I. Molina (University of Granada / Spain) Scientific ThemesAnticancer Therapy, Kinase Inhibitors, Bioorthogonal Prodrugs, Palladium Implants, NanotechnologyTechnology ExpertiseSmall Molecule Synthesis and Peptides, Medicinal Chemistry, Design and Development of Prodrugs, Target ID and Imaging Tools, Heterogeneous Catalysts This article was published on 2024-09-23